Diabetes Diminishes the Portal-Systemic Collateral Vascular Response to Vasopressin via Vasopressin Receptor and Gα Proteins Regulations in Cirrhotic Rats

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Lee, Jing Yi ^a   Huo, Teh Ia ^a,b   Wang, Sun Sang ^a,b   Huang, Hui Chun ^a,b   Lee, Fa Yauh ^a,b   Lin, Han Chieh ^a,b   Chuang, Chiao Lin ^a,b   Lee, Shou Dong ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; GLUCOSE; MESSENGER RNA; MOZAVAPTAN; STREPTOZOCIN; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; HEMODYNAMICS; LIVER CIRRHOSIS; MALE; NONHUMAN; PERFUSION PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; RAT; SPLENORENAL SHUNT; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; ARGININE VASOPRESSIN; BLOOD GLUCOSE; COLLATERAL CIRCULATION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUCOSE; GTP-BINDING PROTEIN ALPHA SUBUNITS; HEMODYNAMICS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; RATS; RECEPTORS, VASOPRESSIN;

RATTUS;

EID: 84879968904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067703     Document Type: Article

References (42)

1. García-Pagán JC, Gracia-Sancho J, Bosch J, (2012) Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol 57: 458-461.
2. Garcia-Tsao G, Bosch J, Groszmann RJ, (2008) Portal hypertension and variceal bleeding - unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology 47: 1764-1772.
3. Huang HC, Haq O, Utsumi T, Sethasine S, Abraldes JG, et al. (2012) Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure. J Cell Mol Med 16: 1125-1133.
4. Yin ZH, Liu XY, Huang RL, Ren SP, (2005) Expression of TNF-alpha and VEGF in the esophagus of portal hypertensive rats. World J Gastroenterol. 11: 1232-1236.
5. Garcia-Tsao G, Bosch J, (2010) Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 362: 823-832.
6. Miñano C, Garcia-Tsao G, (2010) Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am 39(3): 681-695.
7. Chan CC, Wang SS, Lee FY, Chang FY, Lin HC, et al. (2005) Effects of vasopressin on portal-systemic collaterals of cirrhotic rats. Scand J Gastroenterol 40: 83-89.
8. Chan CC, Lee FY, Wang SS, Chang FY, Lin HC, et al. (1999) Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin. Hepatology 30: 630-635.
9. Hennenberg M, Biecker E, Trebicka J, Jochem K, Zhou Q, et al. (2006) Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology 130: 838-854.
10. Kruszynska YT, Home PD, McIntyre N, (1991) Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 14: 103-111.
11. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G, (1994) Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 19: 616-627.
12. García-Compeán D, Jáquez-Quintana JO, Lavalle-González FJ, Reyes-Cabello E, González-González JA, et al. (2012) The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study. Ann Hepatol 11: 240-248.
13. Khan ZA, Chakrabarti S, (2003) Endothelins in chronic diabetic complications. Can J Physiol Pharmacol 81: 622-634.
14. Taylor PD, Poston L, (1994) The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br J Pharmacol 113: 801-808.
15. Mori A, Saigo O, Sakamoto K, Nakahara T, Ishii K, (2010) Hyperglycemia impairs acetylcholine-induced vasodilation of retinal arterioles through polyol pathway-independent mechanisms in rats. J Pharmacol Sci 112: 336-342.
16. Mayhan WG, Simmons LK, Sharpe GM, (1991) Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol 260: H319-326.
17. Sharma K, Deelman L, Madesh M, Kurz B, Ciccone E, et al. (2003) Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells. Am J Physiol Renal Physiol 285: F1258-1270.
18. Turlapaty PDMV, Lum G, Altura BM, (1980) Vascular responsiveness and serum biochemical parameters in alloxan diabtes mellitus. Am J Physiol 239: E412-421.
19. Sarubbi D, McGiff JC, Quilley J, (1989) Renal vascular responses and eicosanoid release in diabetic rats. Am J Physiol 257: F762-768.
20. Franco D, Gigou M, Szekely AM, Bismuth H, (1979) Portal hypertension after bile duct obstruction. Effect of the bile diversion on portal pressure in the rat. Arch Surg 114: 1064-1067.
21. Baluchnejadmojarad T, Roghani M, (2003) Garlic extract attenuates time-dependent changes in the reactivity of isolated aorta in streptozotocin-diabetic rats. Life Sci 73: 2281-2289.
22. Rosenblum WI, Bryan D, Choi SC, (1985) Effect of diabetes on microvascular responses in mouse mesentery. Microcirc Endothelium Lymphatics 2: 195-205.
23. Hostetter TH, Troy JL, Brenner BM, (1981) Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415.
24. Garcia-Villalon AL, Sanz E, Monge L, Fernandez N, Martinez MA, et al. (2003) Vascular reactivity to vasopressin during diabetes: gender and regional differences. Eur J Pharmacol 459: 247-254.
25. Sanz E, Fernandez N, Monge L, Climent B, Dieguez G, et al. (2003) Role of K(+) channels in the coronary and renal vascular reactivity to vasopressin in diabetic rats. Eur J Pharmacol 471: 35-40.
26. Williams B, Tsai P, Schrier RW, (1992) Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells. Role of protein kinase C. J Clin Invest 90: 1992-1999.
27. Trinder D, Phillips PA, Stephenson JM, Risvanis J, Aminian A, et al. (1994) Vasopressin V1 and V2 receptors in diabetes mellitus. Am J Physiol 266: E217-223.
28. Phillips PA, Risvanis J, Hutchins AM, Burrell LM, MacGregor D, et al. (1995) Down-regulation of vasopressin V1a receptor mRNA in diabetes mellitus in the rat. Clin Sci 88: 671-674.
29. Medina P, Segarra G, Vila JM, Chuan P, Domenech C, et al. (1999) V2-receptor-mediated relaxation of human renal arteries in response to desmopressin. Am J Hypertens 12: 188-193.
30. Tamaki T, Kiyomoto K, He H, Tomohiro A, Nishiyama A, et al. (1996) Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney Int 49: 722-729.
31. Tagawa T, Imaizumi T, Shiramoto M, Endo T, Hironaga K, et al. (1995) V2 receptor-mediated vasodilation in healthy humans. J Cardiovasc Pharmacol 25: 387-392.
32. Raimondi L, De Paoli P, Mannucci E, Lonardo G, Sartiani L, et al. (2004) Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats. Diabetes 53: 1927-1933.
33. Nelson LR, Bulun SE, (2001) Estrogen production and action. J Am Acad Dermatol 45: S116-124.
34. McNeill AM, Zhang C, Stanczyk FZ, Duckles SP, Krause DN, (2002) Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33: 1685-1691.
35. Heinemann A, Schuligoi RLippe IT, Stauber RE, (2009) Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats. Pharmacology 83: 26-32.
36. Chang CC, Chuang CL, Lee FY, Wang SS, Lin HC, et al. (2013) Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. Clin Sci (Lond) 124: 457-466.
37. Huang HC, Chang CC, Wang SS, Lee FY, Teng TH, et al. (2012) The roles of angiotensin? receptors in the portosystemic collaterals of portal hypertensive and cirrhotic rats. J Vasc Res 49: 160-168.
38. Chan CC, Wang SS, Lee FY, Chang FY, Lin HC, et al. (2004) Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats. Eur J Clin Invest 34: 290-296.
39. Hollinger MA, (1982) Biochemical evidence for pulmonary endothelial cell injury after carbon tetrachloride administration in mice. J Pharmacol Exp Ther 222: 641-644.
40. Badál P, Kristová V, Cerná A, Janega P, Pechánová O, et al. (2006) Red wine polyphenols prevent endothelial damage induced by CCl4 administration. Physiol Res 55: 245-251.
41. Roden M, (2006) Mechanisms of Disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2: 335-348.
42. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H, (2009) Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 15: 280-288.